Drug recall · September 9, 2026
traZODone Hydrochloride Tablets recall
Why: Presence of Foreign Tablets/Capsules
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
traZODone Hydrochloride Tablets, USP, 50 mg, Rx only, 100 Tablets, Manufactured in Croatia By: Pliva Hrvatska d.o.o, Zagreb, Croatia, Manufactured For: Teva Pharmaceuticals, Parsippany, NJ 07054, NDC 50111-560-01
- Lots / codes
Lot: 1394026, Exp. 02/2028.
- Quantity
- 175,392 bottles
- Company
- Teva Pharmaceuticals USA, Inc, Parsippany, NJ
- Distribution
- U.S. Nationwide
- Initiated
- August 24, 2026 · Voluntary: Firm initiated
- Classified
- September 8, 2026
- Reported
- September 9, 2026
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Trazodone
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.